

Instance: composition-en-2128cb95d4d26d25d7fa2c3944c0ae92
InstanceOf: CompositionUvEpi
Title: "Composition for ranexa Package Leaflet"
Description:  "Composition for ranexa Package Leaflet"
Usage: #inline

* identifier.system = ""

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - ranexa"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  What is in this leaflet  
1. What Ranexa is and what it is used for 
2. What you need to know before you take Ranexa 
3. How to take Ranexa 
4. Possible side effects 
5. How to store Ranexa 
6. Contents of the pack and other  information 
         </div>"""   
          

* section[=].section[+]
  * title =  "1. What ranexa is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What ranexa is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Ranexa is a medicine used in combination with other medicines to treat angina pectoris, which is a 
chest pain or discomfort that you feel anywhere along the upper part of your body between your neck 
and upper abdomen, often brought on by exercise or too much activity.  </p>
<p>You must talk to a doctor if you do not feel better or if you feel worse. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take ranexa"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take ranexa"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Ranexa 
- if you are allergic to ranolazine or any of the other ingredients of this medicine listed in section 6 
of this leaflet. 
- if you have severe kidney problems. 
- if you have moderate or severe liver problems. 
- if you are using certain medicines to treat bacterial infections (clarithromycin, telithromycin), 
fungal infections (itraconazole, ketoconazole, voriconazol, posaconazol), HIV infection (protease 
inhibitors), depression (nefazodone) or heart rhythm disorders (e.g. quinidine, dofetilide, or 
sotalol). </p>
<p>Warning and precautions 
Talk to your doctor before taking Ranexa: 
- if you have mild or moderate kidney problems. 
- if you have mild liver problems. 
- if you have ever had an abnormal electrocardiogram (ECG). 
- if you are elderly.<br />
- if you have low weight (60 kg or less). 
- if you have heart failure. </p>
<p>Your doctor may decide to give you a lower dose or take other precautions if any of these apply to 
you. </p>
<p>Using other medicines and Ranexa 
Do not use the following medicines if you take Ranexa: 
- certain medicines to treat bacterial infections (clarithromycin, telithromycin), fungal infections 
(itraconazole, ketoconazole, voriconazole, posaconazole), HIV infection (protease inhibitors), 
depression (nefazodone), or heart rhythm disorders (e.g. quinidine, dofetilide, or sotalol). </p>
<p>Tell your doctor or pharmacist before you take Ranexa if you use: 
- certain medicines to treat a bacterial infection (erythromycin), or a fungal infection (fluconazole), 
a medicine used to prevent rejection of a transplanted organ (ciclosporin), or if you are taking 
some heart tablets such as diltiazem or verapamil. These medicines may cause an increase in the 
number of side effects, such as dizziness, nausea, or vomiting, which are possible side effects of 
Ranexa (see section 4). Your doctor may decide to give you a lower dose.<br />
- medicines to treat epilepsy or another neurologic disorder (e.g. phenytoin, carbamazepine, or 
phenobarbital); are taking rifampicin for an infection (e.g. tuberculosis); or are taking the herbal 
remedy St. John's Wort, as these medicines may cause Ranexa to be less effective. 
- heart medicines containing digoxin or metoprolol, as your doctor may want to change the dose of 
this medicine whilst you are taking Ranexa. 
- certain medicines to treat allergies (e.g. terfenadine, astemizole, mizolastine), heart rhythm 
disorders (e.g. disopyramide, procainamide), and depression (e.g. imipramine, doxepin, 
amitriptyline), as these medicines may affect your ECG. 
- certain medicines to treat depression (bupropion), psychosis, HIV infection (efavirenz), or cancer 
(cyclophosphamide).<br />
- certain medicines to treat high levels of cholesterol in the blood (e.g. simvastatin, lovastatin, 
atorvastatin). These medicines may cause muscle pain and muscle injury. Your doctor may decide 
to change the dose of this medicine while you are taking Ranexa. 
- certain medicines used to prevent transplanted organ rejection (e.g. tacrolimus, ciclosporin, 
sirolimus, everolimus) as your doctor may decide to change the dose of this medicine while you 
are taking Ranexa.  </p>
<p>Tell your doctor or pharmacist if you are using or have recently used or might use any other 
medicines. </p>
<p>Ranexa with food and drink 
Ranexa can be taken with or without food. While being treated with Ranexa, you should not drink 
grapefruit juice. </p>
<p>Pregnancy 
You should not take Ranexa if you are pregnant unless your doctor has advised you to do so.  </p>
<p>Breast-feeding 
You should not take Ranexa if you are breast-feeding. Ask your doctor for advice if you are breast-
feeding.  </p>
<p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor for advice before taking this medicine. </p>
<p>Driving and using machines 
No studies on the effects of Ranexa on the ability to drive and use machines have been performed. Ask 
your doctor for advice about driving or using machines.  </p>
<p>Ranexa may cause side effects such as dizziness (common), blurred vision (uncommon), confusional 
state (uncommon), hallucination (uncommon), double vision (uncommon), coordination problems 
(rare), that may affect your ability to drive or use machines. If you experience these symptoms, do not 
drive or operate machinery until they have resolved completely. </p>
<p>Ranexa 750 mg prolonged-release tablets contain the azo colouring agent E102. This colouring 
agent- may cause allergic reactions. </p>
<p>Ranexa 750 mg prolonged-release tablets contain lactose monohydrate. If you have been told by 
your doctor that you have an intolerance to some sugars, contact your doctor before taking this 
medicinal product. </p>
<p>This medicine contains less than 1 mmol sodium (23 mg) per prolonged-release tablet, that is to say 
essentially ‘sodium-free’. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take ranexa"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take ranexa"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor has told you to. Check with your doctor or 
pharmacist if you are not sure.   </p>
<p>Always swallow the tablets whole with water. Do not crush, suck, or chew the tablets or break them in 
half, as this might affect the way the medicine is released from the tablets into your body. </p>
<p>The starting dose for adults is one 375 mg tablet twice a day. After 2−4 weeks, your doctor may 
increase the dose to get the right effect. The maximum dose of Ranexa is 750 mg twice a day. </p>
<p>It is important that you tell your doctor if you get side effects such as dizziness or feeling or being 
sick. Your doctor may lower your dose or, if this is not sufficient, stop treatment with Ranexa. </p>
<p>Use in children and adolescents 
Children and adolescents under 18 years old should not take Ranexa. </p>
<p>If you take more Ranexa than you should 
If you accidentally take too many Ranexa tablets or take a higher dose than recommended by your 
doctor, it is important that you tell your doctor at once. If you cannot contact your doctor, go to the 
nearest accident and emergency department. Take along any tablets that are left, including the 
container and the carton, so that the hospital staff can easily tell what you have taken.   </p>
<p>If you forget to take Ranexa 
If you forget to take a dose, take it as soon as you remember unless it is nearly time (less than 6 hours) 
to take your next dose. Do not take a double dose to make up for a forgotten dose. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.  </p>
<p>You should stop taking Ranexa and see your doctor immediately if you experience the following 
symptoms of angioedema, which is a rare condition but can be severe: 
* swollen face, tongue, or throat 
* difficulty swallowing 
* hives or difficulty breathing </p>
<p>Tell your doctor if you experience common side effects such as dizziness or feeling sick or vomiting.<br />
Your doctor may lower your dose or stop treatment with Ranexa. </p>
<p>Other side effects you may experience include the following: </p>
<p>Common side effects (occur in 1 to 10 users in 100) are:<br />
Constipation 
Dizziness 
Headache 
Feeling sick, vomiting 
Feeling weak </p>
<p>Uncommon side effects (occur in 1 to 10 users in 1,000) are:<br />
Altered sensation 
Anxiety, difficulty sleeping, confusional state, hallucination 
Blurred vision, visual disturbance 
Changes in sensation (touch or taste), tremor, feeling tired or sluggish, sleepiness or drowsiness, 
faint or fainting, dizziness upon standing<br />
Dark urine, blood in urine, difficulty urinating 
Dehydration 
Difficulty breathing, cough, nose bleed 
Double vision 
Excessive sweating, itching 
Feeling swollen or bloated 
Hot flushes, low blood pressure<br />
Increases in a substance called creatinine or increases in urea in your blood, increase in blood 
platelets or white blood cells, changes in ECG heart tracing 
Joint swelling, pain in extremity 
Loss of appetite and/or weight loss 
Muscle cramp, muscle weakness 
Ringing in the ears and/or feeling a spinning sensation 
Stomach pain or discomfort, indigestion, dry mouth, or wind  </p>
<p>Rare side effects (occur in 1 to 10 users in 10,000) are: 
A lack of ability to urinate 
Abnormal laboratory values for liver <br />
Acute kidney failure 
Change in sense of smell, numbness in mouth or lips, impaired hearing 
Cold sweat, rash 
Coordination problems 
Decrease in blood pressure upon standing 
Decreased or loss of consciousness 
Disorientation 
Feeling of coldness in hands and legs 
Hives, allergic skin reaction 
Impotence 
Inability to walk due to imbalance 
Inflammation of pancreas or intestine <br />
Loss of memory 
Throat tightness 
Low level of sodium in the blood (hyponatremia) which can cause tiredness and confusion, muscle 
twitching, cramps, and coma.  </p>
<p>Not known side effects (frequency cannot be estimated from the available data) are: 
Myoclonus </p>
<p>Reporting of side effects </p>
<p>If you get any any side effects talk to your doctor or pharmacist. This include any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine.   </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store ranexa"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store ranexa"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on each blister strip of tablets and on the 
outside of the carton and bottle after EXP.   </p>
<p>This medicinal product does not require any special storage conditions. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help  protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Ranexa contains 
The active substance in Ranexa is ranolazine. Each tablet contains 375 mg, 500 mg, or 750 mg 
ranolazine. </p>
<p>The other ingredients are: hypromellose, magnesium stearate, methacrylic acid-ethyl acrylate 
copolymer, microcrystalline cellulose, sodium hydroxide, titanium dioxide and carnauba wax. </p>
<p>Depending on the tablet strength, the tablet coatings also contain: 
375 mg tablet:  macrogol, polysorbate 80, Blue #2/Indigo Carmine Aluminium Lake (E132) 
500 mg tablet:   macrogol, talc, polyvinyl alcohol-part hydrolyzed, iron oxide yellow (E172), iron 
oxide red (E172) 
750 mg tablet:  glycerol triacetate, lactose monohydrate, Blue #1/Brilliant Blue FCF Aluminium Lake 
(E133) and Yellow #5/Tartrazine Aluminium Lake (E102) </p>
<p>What Ranexa looks like and contents of the pack 
Ranexa prolonged-release tablets are oval shaped tablets. 
The 375 mg tablets are pale blue and are engraved with 375 on one side. 
The 500 mg tablets are light orange and are engraved with 500 on one side. 
The 750 mg tablets are pale green and are engraved with 750 on one side. </p>
<p>Ranexa is supplied in cartons containing 30, 60, or 100 tablets in blister strips or 60 tablets in plastic 
bottles.  Not all pack-sizes may be marketed. </p>
<p>Marketing Authorisation Holder 
Menarini International Operations Luxembourg S.A. 
1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg </p>
<p>Manufacturer </p>
<p>Menarini - Von Heyden GmbH 
Leipziger Straβe 7-01097 Dresden<br />
Germany </p>
<p>or  </p>
<p>Berlin-Chemie AG 
Glienicker Weg 12489 Berlin 
Germany </p>
<p>For any information about this medicinal product, please contact the local representative of the 
Marketing Authorisation Holder. </p>
<p>België/Belgique/Belgien 
Menarini Benelux NV/SA 
Tél/Tel: + 32 (0)2 721 4Lietuva 
UAB “BERLIN-CHEMIE MENARINI 
BALTIC” 
Tel: +370 52 691<br />
България 
 “Берлин-Хеми/А. Менарини България” 
ЕООД 
тел.: +359 2 454 0 
Luxembourg/Luxemburg 
Menarini Benelux NV/SA 
Tél/Tel: + 32 (0)2 721 4Česká republika 
Berlin-Chemie/A.Menarini Ceska republika 
s.r.o. 
Tel: +420 267 199<br />
Magyarország 
Berlin-Chemie/A. Menarini Kft. 
Tel.: +36 17997Danmark 
Menarini International Operations Luxembourg 
S.A. 
Tel: +352 264 
Malta 
Menarini International Operations Luxembourg 
S.A. 
Tel: +352 264 
Deutschland 
Berlin-Chemie AG 
Tel: +49 (0) 30 67 
Nederland 
Menarini Benelux NV/SA 
Tel: +32 (0)2 721 4 </p>
<p>Eesti 
OÜ Berlin-Chemie Menarini Eesti 
Tel: +372 667 5 </p>
<p>Norge 
Menarini International Operations Luxembourg 
S.A. 
Tlf: +352 264 </p>
<p>Ελλάδα 
MENARINI HELLAS AE 
Τηλ: +30 210 8316111-Österreich 
A. Menarini Pharma GmbH. 
Tel: +43 1 879 95 85-0 </p>
<p>España 
Laboratorios Menarini S.A. 
Tel: +34-93 462 88 Polska 
Berlin-Chemie/Menarini Polska Sp. z o.o. 
Tel.: +48 22 566 21 France 
MENARINI France 
Tél: +33 (0)1 45 60 77 Portugal 
A. Menarini Portugal – Farmacêutica, S.A. 
Tel: +351 210 935 Hrvatska 
Berlin-Chemie Menarini Hrvatska d.o.o. 
Tel: + 385 1 4821 România 
Berlin-Chemie A. Menarini S.R.L. 
Tel: +40 211 232 34 Ireland 
A. Menarini Pharmaceuticals Ltd 
Tel: +353 1 284 6Slovenija 
Berlin-Chemie / A. Menarini Distribution 
Ljubljana d.o.o. 
Tel: +386 01 300 2 
Ísland 
Menarini International Operations Luxembourg 
S.A. 
Sími: +352 264 
Slovenská republika 
Berlin-Chemie / A. Menarini Distribution 
Slovakia s.r.o 
Tel: +421 2 544 30 Italia 
A. Menarini Industrie Farmaceutiche Riunite 
s.r.l. 
Tel: +39-055 56 
Suomi/Finland 
Berlin-Chemie/A.Menarini Suomi OY 
Puh/Tel: +358 403 000 Κύπρος 
MENARINI HELLAS AE 
Τηλ: +30 210 8316111-Sverige 
Menarini International Operations Luxembourg 
S.A. 
Tel: +352 264Latvija 
SIA Berlin-Chemie/Menarini Baltic 
Tel: +371 67103United Kingdom (Northern Ireland) 
A. Menarini Farmaceutica Internazionale S.R.L. 
Tel: +44 (0)1628 856 </p>
<p>This leaflet was last revised in </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site 
http://www.ema.europa.eu. </p>         </div>"""      

